Clinical non‐remission at post‐treatment · depression
It is very uncertain whether third wave CBT changes clinical non‐remission at post‐treatment compared with TAU (very low certainty).
1 finding from 1 review
Depression levels at post‐treatment · depression
1 finding from 1 review
Anxiety · depression
1 finding from 1 review
Social adjustment levels at post‐treatment— behavioural activation vs TAU Work and Social Ajustment Scale (WSAS) · depression
1 finding from 1 review
Prodromal symptoms: transition to psychosis Endpoint data (events) · people in the prodromal stage of psychosis
It is very uncertain whether group B cognitive behavioural therapy: cognitive behavioural therapy… changes prodromal symptoms: transition to psychosis Endpoint data (events)… compared with needs‐based intervention (very low certainty).
1 finding from 1 review
Global state: clinically important change in global state · people in the prodromal stage of psychosis
1 finding from 1 review
Mental state: psychopathology Total endpoint data, BPRS (higher score = worse, scale from: 0‐126) · people in the prodromal stage of psychosis
1 finding from 1 review
Behaviour: clinically important change in behaviour · people in the prodromal stage of psychosis
1 finding from 1 review
Adverse effects: at least one serious adverse event · people in the prodromal stage of psychosis
1 finding from 1 review
QoL · people in the prodromal stage of psychosis
1 finding from 1 review
Satisfaction with treatment: 1. Leaving the study early ‐ long term · people in the prodromal stage of psychosis
It is very uncertain whether group B cognitive behavioural therapy: cognitive behavioural therapy… changes satisfaction with treatment: leaving the study early (events)… compared with needs‐based intervention (very low certainty).
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
1 finding from 1 review
Successful discontinuation of BZDs‐ post treatment Objective and subjective · patients with BZD harmful use, abuse or dependence
CBT (plus taper) probably leads to higher successful discontinuation of BZDs‐ post treatment Objective and… compared with taper (moderate certainty).
1 finding from 1 review
Successful discontinuation of BZDs‐ 12 month · patients with BZD harmful use, abuse or dependence
CBT (plus taper) showed no clear difference in successful discontinuation of BZDs‐ 12 month compared with taper (moderate certainty).
1 finding from 1 review
Reduce BZDs> 50% ‐ post treatment Objective · patients with BZD harmful use, abuse or dependence
CBT (plus taper) showed no clear difference in reduce BZDs> 50% ‐ post treatment Objective compared with taper (low certainty).
1 finding from 1 review
Reduce BZDs> 50% ‐ 12 month · patients with BZD harmful use, abuse or dependence
CBT (plus taper) showed no clear difference in reduce BZDs> 50% ‐ 12 month compared with taper (low certainty).
1 finding from 1 review
Severity of PTSD symptoms · Adults with co‐morbid PTSD and SMI
1 finding from 1 review
Severity of PTSD symptoms · Adults with co‐morbid PTSD and SMI
1 finding from 1 review
Quality of life: 1. General quality of life · Adults with co‐morbid PTSD and SMI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Symptoms of co‐morbid psychosis: 1. Overall mental state · Adults with co‐morbid PTSD and SMI
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found